Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

Experimental pill versions of GLP-1 weight loss drugs by Novo Nordisk and Eli Lilly will receive FDA priority review. Read ...

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

Thirteen drugs for cancer and diabetes have been added to the list of essential medicines exempted from value-added tax or ...

The US president’s sudden policy reversal on weight-loss drugs like Ozempic and Wegovy could reshape the global market, from ...

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

The results were published in The New England Journal of Medicine as part of the OASIS 4 phase 3 trial. The findings show ...

Pfizer has won the week-long bidding war for Metsera with an upwardly revised up-to-$10 billion offer matching that of rival Novo Nordisk—and more than a little help from Washington.

Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk ...

Hosts David and Gina explore the unexpected origins of blockbuster diabetes and weight-loss drugs like Ozempic and Wegovy ...

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

According to renowned endocrinologist Dr Shashank Joshi, a steep cut in the prices of Wegovy will help improve access and affordability. “But it has to be cautioned that weight loss drugs are not ...